BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31606225)

  • 1. Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia.
    Merie R; Gabriel G; Shafiq J; Vinod S; Barton M; Delaney GP
    Radiother Oncol; 2019 Dec; 141():41-47. PubMed ID: 31606225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of radiotherapy underutilisation measured by survival shortfall, years of potential life lost and disability-adjusted life years lost in New South Wales, Australia.
    Batumalai V; Shafiq J; Gabriel G; Hanna TP; Delaney GP; Barton M
    Radiother Oncol; 2018 Nov; 129(2):191-195. PubMed ID: 29983259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of four methods for estimating actual radiotherapy utilisation using the 45 and Up Study cohort in New South Wales, Australia.
    Yap ML; O'Connell DL; Goldsbury D; Weber M; Barton M
    Radiother Oncol; 2019 Feb; 131():14-20. PubMed ID: 30773181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated With Radiotherapy Utilisation In New South Wales, Australia: Results From The 45 and Up Study.
    Yap ML; O'Connell DL; Goldsbury D; Weber M; Barton M
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):282-291. PubMed ID: 32007353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of travel distance on radiotherapy utilization in NSW and ACT.
    Gabriel G; Barton M; Delaney GP
    Radiother Oncol; 2015 Nov; 117(2):386-9. PubMed ID: 26243679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing criterion-based benchmarking for the appropriate use of radiotherapy.
    Barton MB; Gabriel GS; Delaney GP
    Radiother Oncol; 2018 Sep; 128(3):406-410. PubMed ID: 29880221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 'Catch Up' Plan for radiotherapy in New South Wales to 2012.
    Morgan G; Barton M; Crossing S; Bull C; Penman A
    J Med Imaging Radiat Oncol; 2009 Aug; 53(4):419-30. PubMed ID: 19695050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia.
    Mackenzie P; Vajdic C; Delaney G; Gabriel G; Agar M; Comans T; Barton M
    Tech Innov Patient Support Radiat Oncol; 2020 Dec; 16():17-23. PubMed ID: 33385070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer treatment and survival differences in women in remote and socioeconomically disadvantaged areas, as demonstrated by linked data from New South Wales (NSW), Australia.
    Buckley E; Elder E; McGill S; Kargar ZS; Li M; Roder D; Currow D
    Breast Cancer Res Treat; 2021 Jul; 188(2):547-560. PubMed ID: 33748922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decade of investment in radiotherapy in New South Wales: why does the gap between optimal and actual persist?
    Barton MB; Delaney GP
    J Med Imaging Radiat Oncol; 2011 Aug; 55(4):433-41. PubMed ID: 21843180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?
    Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
    J Geriatr Oncol; 2014 Jul; 5(3):323-30. PubMed ID: 24656735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy utilization in New South Wales from 1996 to 1998.
    Barton M
    Australas Radiol; 2000 Aug; 44(3):308-14. PubMed ID: 10974725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization of radiotherapy for lung cancer in New South Wales, Australia.
    Vinod SK; Simonella L; Goldsbury D; Delaney GP; Armstrong B; O'Connell DL
    Cancer; 2010 Feb; 116(3):686-94. PubMed ID: 19957325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What factors affect the odds of NSW cancer patients presenting with localised as opposed to more advanced cancer?
    Tracey EA; Roder DM; Currow DC
    Cancer Causes Control; 2012 Feb; 23(2):255-62. PubMed ID: 22120005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy access in Belgium: How far are we from evidence-based utilisation?
    Lievens Y; De Schutter H; Stellamans K; Rosskamp M; Van Eycken L;
    Eur J Cancer; 2017 Oct; 84():102-113. PubMed ID: 28802187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of geographic area level on measuring socioeconomic disparities in cancer survival in New South Wales, Australia: A period analysis.
    Stanbury JF; Baade PD; Yu Y; Yu XQ
    Cancer Epidemiol; 2016 Aug; 43():56-62. PubMed ID: 27391547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Country of birth and non-small cell lung cancer incidence, treatment, and outcomes in New South Wales, Australia: a population-based linkage study.
    Little A; Roder D; Zhao GW; Challam S; Malalasekera A; Currow D
    BMC Pulm Med; 2022 Sep; 22(1):366. PubMed ID: 36163039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes to radiotherapy utilisation in Western NSW after the opening of a local service.
    Butler SM
    J Med Radiat Sci; 2017 Dec; 64(4):251-258. PubMed ID: 28160454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pattern of Use of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer in New South Wales, Australia, 2008 to 2012.
    Delaney GP; Gandhidasan S; Walton R; Terlich F; Baker D; Currow D
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):266-272. PubMed ID: 27473814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of suicide in New South Wales men with prostate cancer: Analysis of linked population-wide data.
    Smith DP; Calopedos R; Bang A; Yu XQ; Egger S; Chambers S; O'Connell DL
    PLoS One; 2018; 13(6):e0198679. PubMed ID: 29897979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.